Citryll was founded by Renato Chirivi in 2015.

Who are Citryll's investors?

Citryll's investors include BioGeneration Ventures, Pureos Bioventures, Seventure Partners, Forbion, Johnson & Johnson Innovation – JJDC, BOM, Curie Capital, Novartis Venture Fund.

How much funding has Citryll raised?

Citryll has disclosed $92.5M raised across 1 round.

Where is Citryll headquartered?

Citryll is headquartered in Oss, NL.

Citryll

Oss, NL · Founded 2015 · 38 employees on LinkedIn · 8 known investors

Find your way into Citryll

Paths you didn't know you had: your email and LinkedIn already hold routes to the Citryll team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones. The company is advancing clinical programs in immune-mediated inflammatory diseases, with a current focus on rheumatoid arthritis and hidradenitis suppurativa.

Biotech Healthtech Medical Devices

Founders & leadership

Citryll was founded in 2015 by Renato Chirivi.

Renato ChiriviCo-founder (former CSO)Renato Chirivi is co-founder and former Chief Scientific Officer of Citryll, a clinical-stage biotech company. He has research experience in molecular immunology, antibody discovery and engineering, and protein citrullination, developed through roles at the Mario Negri Institute for Pharmacological Research, The Scripps Research Institute, Nijmegen Center for Molecular Life Sciences, and ModiQuest BV.

Board

Paul Peter TakChair of the Board

Investors · 8

BioGeneration Ventures✓ confirmed by CitryllNaarden

How we know: the company's own site · BioGeneration Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Pureos Bioventures✓ confirmed by CitryllPfäffikon

How we know: Pureos Bioventures's portfolio page · the company's own site · funding news · Not right? Tell us

Seventure Partners✓ confirmed by CitryllParis

How we know: the company's own site · Seventure Partners's portfolio page · a partner's Signal profile · Not right? Tell us

Forbion✓ confirmed by CitryllNaarden

How we know: the company's own site · a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Johnson & Johnson Innovation – JJDC✓ confirmed by CitryllNew Brunswick

How we know: the company's own site · Not right? Tell us

BOMlisted by BOMTilburg · $540K – $5.8M

How we know: BOM's portfolio page · Not right? Tell us

Curie Capitallisted by Curie CapitalAmsterdam

How we know: funding news · Not right? Tell us

Novartis Venture Fundlisted by Novartis Venture FundBasel · $5M – $25M

How we know: Novartis Venture Fund's portfolio page · a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

$92.5M disclosed across 1 round · 2024

$92.5MSeries BDec 2024 · 2 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

About Citryll | Innovation of Medicine | Citryllcitryll.com · Feb 2025

Oss-based Citryll secures €85 million Series B funding to advance NET-targeting therapy | EU-Startupseu-startups.com · Dec 2024

Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disordersglobenewswire.com · Dec 2024

Frequently asked questions

What does Citryll do?: Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones. The company is advancing clinical programs in immune-mediated inflammatory diseases, with a current focus on rheumatoid arthritis and hidradenitis suppurativa.
Who founded Citryll?: Citryll was founded by Renato Chirivi in 2015.
Who are Citryll's investors?: Citryll's investors include BioGeneration Ventures, Pureos Bioventures, Seventure Partners, Forbion, Johnson & Johnson Innovation – JJDC, BOM, Curie Capital, Novartis Venture Fund.
How much funding has Citryll raised?: Citryll has disclosed $92.5M raised across 1 round.
Where is Citryll headquartered?: Citryll is headquartered in Oss, NL.